Eyepoint Pharmaceuticals Inc Financial Flexibility Index
Eyepoint Pharmaceuticals Inc financial flexibility index. Eyepoint Pharmaceuticals Inc (EYPT) has a Financial Flexibility Index of -1.14x as of September 2025. Free cash flow of $-58.56 Million (operating CF $-59.35 Million minus capex $798.00K) represents -1% of total liabilities ($51.51 Million). See EYPT cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Eyepoint Pharmaceuticals Inc (2002–2024)
Financial flexibility index of Eyepoint Pharmaceuticals Inc from 2002 to 2024. Historical Financial Flexibility Index trend for Eyepoint Pharmaceuticals Inc across 23 annual periods. Check Eyepoint Pharmaceuticals Inc (EYPT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Eyepoint Pharmaceuticals Inc Financial Flexibility Index by Year (2002–2024)
Eyepoint Pharmaceuticals Inc financial flexibility index by year from 2002 to 2024. Year-by-year free cash flow to debt coverage for Eyepoint Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Eyepoint Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.49x | $-122.17 Million | $-126.23 Million | $81.96 Million | ▼ -2572.1% |
| 2023 | 0.06x | $5.36 Million | $1.88 Million | $88.86 Million | ▲ +108.1% |
| 2022 | -0.75x | $-62.85 Million | $-65.00 Million | $83.99 Million | ▼ -18.4% |
| 2021 | -0.63x | $-49.94 Million | $-50.10 Million | $78.99 Million | ▼ -228.7% |
| 2020 | -0.19x | $-14.07 Million | $-14.44 Million | $73.18 Million | ▲ +78.0% |
| 2019 | -0.87x | $-56.49 Million | $-56.70 Million | $64.64 Million | ▼ -140.4% |
| 2018 | -0.36x | $-21.80 Million | $-21.91 Million | $59.98 Million | ▲ +90.5% |
| 2017 | -3.81x | $-20.34 Million | $-20.49 Million | $5.34 Million | ▼ -152.4% |
| 2016 | -1.51x | $-16.20 Million | $-16.32 Million | $10.74 Million | ▼ -229.8% |
| 2015 | 1.16x | $10.46 Million | $10.30 Million | $9.00 Million | ▲ +186.4% |
| 2014 | -1.35x | $-10.42 Million | $-10.67 Million | $7.75 Million | ▼ -32.6% |
| 2013 | -1.01x | $-8.68 Million | $-8.74 Million | $8.55 Million | ▲ +17.8% |
| 2012 | -1.23x | $-8.60 Million | $-9.00 Million | $6.96 Million | ▼ -293.6% |
| 2011 | -0.31x | $-3.04 Million | $-3.17 Million | $9.68 Million | ▼ -131.6% |
| 2010 | 0.99x | $9.91 Million | $9.90 Million | $9.97 Million | ▲ +263.6% |
| 2009 | -0.61x | $-8.24 Million | $-8.44 Million | $13.56 Million | ▼ -117.5% |
| 2008 | -0.28x | $-4.87 Million | $-5.14 Million | $17.44 Million | ▲ +73.3% |
| 2007 | -1.05x | $-21.13 Million | $-21.21 Million | $20.21 Million | ▼ -119.1% |
| 2006 | -0.48x | $-14.98 Million | $-16.14 Million | $31.40 Million | ▲ +89.0% |
| 2005 | -4.34x | $-6.75 Million | $-9.34 Million | $1.56 Million | ▲ +0.0% |
| 2004 | -4.34x | $-6.75 Million | $-9.34 Million | $1.56 Million | ▼ -15.4% |
| 2003 | -3.76x | $-5.07 Million | $-5.44 Million | $1.35 Million | ▲ +26.8% |
| 2002 | -5.14x | $-3.02 Million | $-3.06 Million | $588.38K | — |